A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

November 23, 2017

Primary Completion Date

April 3, 2019

Study Completion Date

April 3, 2019

Conditions
Insomnia Disorders
Interventions
DRUG

Placebo

Matching placebo will be administered once daily based upon dosing group.

DRUG

JNJ-42847922, 5 mg

JNJ-42847922 will be administered as 5 mg (2\*2.5 mg capsule) oral capsules once daily.

DRUG

JNJ-42847922, 10 mg

JNJ-42847922 will be administered as 10 mg oral capsule once daily.

DRUG

JNJ-42847922, 20 mg

JNJ-42847922 will be administered as 20 mg oral capsule once daily.

DRUG

Zolpidem

Zolpidem will be administered as 5 mg or 10 mg (2\*5mg capsule) oral capsule once daily based upon the local labeling information.

Trial Locations (56)

1200

Cliniques Universitaires Saint Luc, Brussels

2610

Universiteit Antwerpen, Wilrijk

3000

UZ Leuven Gasthuisberg, Leuven

3570

Anima, Alken

9000

Universitair Ziekenhuis Gent, Ghent

10117

Advanced Sleep Research GmbH, Berlin

10629

Emovis GmbH, Berlin

19053

Somni Bene GmbH, Schwerin

19055

Klinische Forschung Schwerin GmbH, Schwerin

20251

CTC North GmbH & Co. KG, Hamburg

21075

Centennial Medical Group, Elkridge

28054

Gastonia Medical Specialty Clinic, Gastonia

28117

Clinical Research of Lake Norman, Mooresville

29464

Clinical Research of Charleston, Mt. Pleasant

30331

Atlanta Center for Medical Research, Atlanta

30342

NeuroTrials Research, Inc., Atlanta

32025

Sarkis Clinical Trials, Lake City

32720

Avail Clinical Research, LLC, DeLand

33135

Suncoast Research Group, Miami

33319

Innovative Clinical Research Inc, Lauderhill

33409

Palm Beach Research Center, West Palm Beach

34471

Renstar Medical Research, Ocala

38043

CHU de Grenoble Hopital Albert Michallon, Isere

45242

CTI Clinical Trial and Consulting Services, Cincinnati

60313

Synexus Clinical Research GmbH, Frankfurt

60634

Chicago Research Center, Chicago

68250

Centre Hospitalier Specialisé de Rouffach, Rouffach

69004

Hopital de La Croix Rousse, Lyon

72211

Preferred Research Partners, Little Rock

72758

Woodland Research Northwest, Rogers

73112

Lynn Health Science Institute, Oklahoma City

75181

Hôpital Hôtel Dieu - Paris, Paris

78731

FutureSearch Trials of Neurology, LP, Austin

89104

Clinical Research Center of Nevada, Las Vegas

91786

Empire Clinical Research, LLC, Upland

92056

Excell Research Inc, Oceanside

92103

Artemis Institute for Clinical Research, San Diego

92801

California Research Trials DBA Orange Country Research Institute, Anaheim

33765-2103

St. Francis Medical Institute, Clearwater

04103

Synexus Clinical Research GmbH, Sachsen

812-0025

SOUSEIKAI PS Clinic, Fukuoka

802-0084

You Ariyoshi Sleep Clinic, Kitakyushu-shi

780-8037

Takedakai Kochi Kagamigawa Hospital, Kochi

830-0011

Kurume University Hospital, Kurume-shi

460-0001

National Hospital Organization Nagoya Medical Center, Nagoya

532-0003

Gokeikai Osaka Kaisei Hospital, Osaka

047-0155

Wellness Boyodai Hospital, Otaru-shi

151-0053

Suimin Sogo Care Clinic Yoyogi, Shibuya-ku

169-0073

Shinjuku Research Park Clinic, Shinjuku-ku

171-0014

Sekino Hospital, Toshima-ku

514-8507

Mie University Hospital, Tsu

223-0059

Kaiseikai Kita Shin Yokohama Internal Medicine Clinic, Yokohama

80 546

Centrum Badan Klinicznych PI House sp z o o, Gdansk

40-123

NZOZ Wielospecjalistyczna Poradnia Lekarska 'Synapsis', Katowice

60-782

Osrodek Badan Klinicznych CROMED, Poznan

50 220

EMC Instytut Medyczny SA, Wroclaw

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03375203 - A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder | Biotech Hunter | Biotech Hunter